Statement Of Cash Flows [Abstract]

BioPorto - Filing #1413942

Concept	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)	—	57,113,000 DKK	57,113,000 DKK	61,562,000 DKK	—	61,562,000 DKK	—
Adjustments to reconcile profit (loss) [abstract]
Adjustments for share-based payments	—	966,000 DKK	—	—	—	5,316,000 DKK	—
Other adjustments for non-cash items	—	310,000 DKK	—	—	—	915,000 DKK	—
Cash flows from (used in) operations	—	69,030,000 DKK	—	—	—	38,353,000 DKK	—
Cash flows from (used in) operating activities	—	64,577,000 DKK	—	—	—	35,616,000 DKK	—
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities	—	130,000 DKK	—	—	—	1,315,000 DKK	—
Purchase of intangible assets, classified as investing activities	—	259,000 DKK	—	—	—	184,000 DKK	—
Cash flows from (used in) investing activities	—	412,000 DKK	—	—	—	1,521,000 DKK	—
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares	—	- DKK	—	—	—	146,620,000 DKK	—
Payments of lease liabilities, classified as financing activities	—	3,099,000 DKK	—	—	—	2,859,000 DKK	—
Cash flows from (used in) financing activities	—	1,101,000 DKK	—	—	—	127,035,000 DKK	—
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes	—	63,888,000 DKK	—	—	—	89,898,000 DKK	—
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents	—	1,468,000 DKK	—	—	—	77,000 DKK	—
Cash and cash equivalents	45,523,000 DKK	—	—	—	107,943,000 DKK	—	18,122,000 DKK